TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,448,000 | -25.9% | 26,439 | +13.6% | 0.00% | -100.0% |
| Q2 2023 | $1,955,000 | +46.3% | 23,273 | +31.9% | 0.00% | – |
| Q1 2023 | $1,336,000 | +372.1% | 17,651 | +285.4% | 0.00% | – |
| Q4 2022 | $283,000 | +515.2% | 4,580 | +308.2% | 0.00% | – |
| Q3 2022 | $46,000 | +820.0% | 1,122 | +643.0% | 0.00% | – |
| Q2 2022 | $5,000 | -88.4% | 151 | -90.5% | 0.00% | – |
| Q1 2022 | $43,000 | -56.1% | 1,592 | -69.1% | 0.00% | – |
| Q4 2021 | $98,000 | -2.0% | 5,145 | +70.6% | 0.00% | – |
| Q3 2021 | $100,000 | -30.6% | 3,016 | -30.2% | 0.00% | – |
| Q2 2021 | $144,000 | +100.0% | 4,318 | +148.3% | 0.00% | – |
| Q1 2021 | $72,000 | +928.6% | 1,739 | +394.0% | 0.00% | – |
| Q4 2020 | $7,000 | +600.0% | 352 | +851.4% | 0.00% | – |
| Q3 2020 | $1,000 | – | 37 | +60.9% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 23 | -62.9% | 0.00% | – |
| Q1 2020 | $1,000 | -94.7% | 62 | -93.9% | 0.00% | – |
| Q4 2019 | $19,000 | +533.3% | 1,015 | +915.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
| Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
| Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
| EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
| RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
| NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
| ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
| Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |